Search
for

    Sort by

    Research 31–60 of 1000+

    1. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    2. Tamsulosin versus finasteride: effect on bother and urinary flow European Urology Supplements · 2002 · 1 citations
    3. Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases Chinese Journal of General Practice · 2011
    4. Economic Issues in the Treatment of BPH European Urology Supplements · 2006 · 11 citations
    5. Misdiagnosis of eosinophilic cystitis: A case report and literature review Medicine · 2024 · 1 citations
    6. Editorial Comment The Journal of Urology · 2006
    7. Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma Journal of endourology case reports · 2019 · 3 citations
    8. Dutasteride Drugs · 2008 · 45 citations
    9. Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? Current Drug Targets · 2015 · 21 citations
    10. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    11. Finasteride Drugs · 1999 · 40 citations
    12. Finasteride in the treatment of patients with benign prostatic hyperplasia: a review Therapeutics and Clinical Risk Management · 2009 · 33 citations
    13. Інгібітор 5α-редуктази дутастерид при лікуванні доброякісної гіперплазії передміхурової залози: системний огляд та мета-аналіз 2021
    14. Long-Term Effectiveness of Finasteride for BPH Journal watch · 2004
    15. Every TURP Is not Just BPH American Journal of Clinical Pathology · 2022
    16. Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. PubMed · 2005 · 38 citations
    17. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction Fertility and Sterility · 2021 · 8 citations
    18. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    19. The clinical applications of five-alpha reductase inhibitors. Canadian Journal of Urology · 2021 · 2 citations
    20. Case report: Heterozygous mutation in HTRA1 causing typical cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy Frontiers in Genetics · 2023 · 1 citations
    21. Les Visiteurs des malades Nature Clinical Practice Urology · 2011
    22. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003 · 1707 citations
    23. Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia European Urology · 2000 · 184 citations
    24. ADVERSE EFFECTS OF OPIOID ANALGESIC DRUGS British Journal of Anaesthesia · 1987 · 183 citations
    25. Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia Current pharmaceutical design · 2006 · 52 citations
    26. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations
    27. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    28. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    29. 술 전 5-알파환원효소억제제의 투여가 120W Greenlight TM HPS 레이저를 이용한 광선택적 전립선기화술에 미치는 영향 The World Journal of Men s Health · 2011 · 9 citations
    30. Long-Term Experience With 5-alpha-Reductase Inhibitors. PubMed · 2003 · 6 citations